Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Carisma Therapeutics Inc. is a clinical-stage cell therapy company. The Company is focused on utilizing the Company¿s macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The Company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. The Company¿s lead product candidate, CT-0508, is a Chimeric Antigen Receptor Macrophage (CAR-M) to be evaluated in a human clinical trial and is intended to treat solid tumors that overexpress HER2. The Company¿s second product candidate, CT-0525, is also intended to treat solid tumors that overexpress HER2, is in preclinical development. Beyond CT-0508 and CT-0525, the Company has a pipeline of cell therapy assets in various stages of pre-clinical development. The Company is also developing in vivo CAR-M gene therapies.
| Last: | $0.1679 |
|---|---|
| Change Percent: | -38.7% |
| Open: | $0.1587 |
| Close: | $0.2739 |
| High: | $0.1698 |
| Low: | $0.147 |
| Volume: | 10,869,262 |
| Last Trade Date Time: | 10/10/2025 12:45:54 pm |
| Market Cap: | $1,682,172 |
|---|---|
| Float: | 30,135,994 |
| Insiders Ownership: | N/A |
| Institutions: | 19 |
| Short Percent: | 1291811% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.carismatx.com |
| Country: | US |
| City: | Philadelphia |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Carisma Therapeutics Inc. (NASDAQ: CARM).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
